外科肿瘤学
计算生物学
精密医学
基因组学
癌症
药物开发
精确肿瘤学
生物信息学
医学
生物
肿瘤科
内科学
基因组
病理
基因
遗传学
药理学
药品
作者
Yuntao Xia,Charles Gawad
标识
DOI:10.1007/s10585-021-10129-4
摘要
Single-cell sequencing technologies have undergone rapid development and adoption by the scientific community in the past 5 years, fueling discoveries about the etiology, pathogenesis, and treatment responsiveness of individual tumor cells within cancer ecosystems. Most of the advancements in our understanding of cancer with these new technologies have focused on basic tumor biology. However, the knowledge produced by these and other studies are beginning to provide biomarkers and drug targets for clinically-relevant subpopulations within a tumor, creating opportunities for the development of biologically-informed, clone-specific combination treatment strategies. Here we provide an overview of the development of the field of single-cell cancer sequencing and provide a roadmap for shepherding these technologies from research tools to diagnostic instruments that provide high-resolution, treatment-directing details of tumors to clinical oncologists.
科研通智能强力驱动
Strongly Powered by AbleSci AI